BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 23138837)

  • 1. Genetic variants in the host restriction factor APOBEC3G are associated with HIV-1-related disease progression and central nervous system impairment in children.
    Singh KK; Wang Y; Gray KP; Farhad M; Brummel S; Fenton T; Trout R; Spector SA
    J Acquir Immune Defic Syndr; 2013 Feb; 62(2):197-203. PubMed ID: 23138837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA alleles are associated with altered risk for disease progression and central nervous system impairment of HIV-infected children.
    Singh KK; Gray PK; Wang Y; Fenton T; Trout RN; Spector SA
    J Acquir Immune Defic Syndr; 2011 May; 57(1):32-9. PubMed ID: 21283014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of H186R polymorphism in exon 4 of the APOBEC3G gene among North Indian individuals.
    Rathore A; Chatterjee A; Yamamoto N; Dhole TN
    Genet Test; 2008 Sep; 12(3):453-6. PubMed ID: 18652534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of HIV-1 Vif variability on progression to pediatric AIDS and its association with APOBEC3G and CUL5 polymorphisms.
    De Maio FA; Rocco CA; Aulicino PC; Bologna R; Mangano A; Sen L
    Infect Genet Evol; 2011 Aug; 11(6):1256-62. PubMed ID: 21571098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. APOBEC3G Variants and Protection against HIV-1 Infection in Burkina Faso.
    Compaore TR; Soubeiga ST; Ouattara AK; Obiri-Yeboah D; Tchelougou D; Maiga M; Assih M; Bisseye C; Bakouan D; Compaore IP; Dembele A; Martinson J; Simpore J
    PLoS One; 2016; 11(1):e0146386. PubMed ID: 26741797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D-related host genetic variants alter HIV disease progression in children.
    Moodley A; Qin M; Singh KK; Spector SA
    Pediatr Infect Dis J; 2013 Nov; 32(11):1230-6. PubMed ID: 23736144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. APOBEC3G expression is dysregulated in primary HIV-1 infection and polymorphic variants influence CD4+ T-cell counts and plasma viral load.
    Reddy K; Winkler CA; Werner L; Mlisana K; Abdool Karim SS; Ndung'u T;
    AIDS; 2010 Jan; 24(2):195-204. PubMed ID: 19996938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coding region variant 186H/R in Exon 4 of APOBEC3G among individuals of Western India.
    Singh H; Marathe S; Nain S; Nema V; Angadi M; Bapat S; Pawar J; Ghate M; Sahay S; Gangakhedkar RR
    APMIS; 2016 May; 124(5):401-5. PubMed ID: 26853443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human apolipoprotein B mRNA-editing enzyme-catalytic polypeptide-like 3G (APOBEC3G) is incorporated into HIV-1 virions through interactions with viral and nonviral RNAs.
    Svarovskaia ES; Xu H; Mbisa JL; Barr R; Gorelick RJ; Ono A; Freed EO; Hu WS; Pathak VK
    J Biol Chem; 2004 Aug; 279(34):35822-8. PubMed ID: 15210704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. APOBEC3-mediated editing in HIV type 1 from pediatric patients and its association with APOBEC3G/CUL5 polymorphisms and Vif variability.
    De Maio FA; Rocco CA; Aulicino PC; Bologna R; Mangano A; Sen L
    AIDS Res Hum Retroviruses; 2012 Jun; 28(6):619-27. PubMed ID: 22145963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. APOBEC3G genetic variants and their influence on the progression to AIDS.
    An P; Bleiber G; Duggal P; Nelson G; May M; Mangeat B; Alobwede I; Trono D; Vlahov D; Donfield S; Goedert JJ; Phair J; Buchbinder S; O'Brien SJ; Telenti A; Winkler CA
    J Virol; 2004 Oct; 78(20):11070-6. PubMed ID: 15452227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Advances in the study of molecular mechanism of APOBEC3G anti-HIV-1].
    Fan B; Cen S; Jiang JD
    Yao Xue Xue Bao; 2008 Jul; 43(7):678-82. PubMed ID: 18819469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of APOBEC3G/F activity to the development of low-abundance drug-resistant human immunodeficiency virus type 1 variants.
    Noguera-Julian M; Cozzi-Lepri A; Di Giallonardo F; Schuurman R; Däumer M; Aitken S; Ceccherini-Silberstein F; D'Arminio Monforte A; Geretti AM; Booth CL; Kaiser R; Michalik C; Jansen K; Masquelier B; Bellecave P; Kouyos RD; Castro E; Furrer H; Schultze A; Günthard HF; Brun-Vezinet F; Metzner KJ; Paredes R;
    Clin Microbiol Infect; 2016 Feb; 22(2):191-200. PubMed ID: 26482266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of APOBEC3G/3F and G-to-A hypermutation levels in HIV-1-infected children with different profiles of disease progression.
    Amoêdo ND; Afonso AO; Cunha SM; Oliveira RH; Machado ES; Soares MA
    PLoS One; 2011; 6(8):e24118. PubMed ID: 21897871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An age-dependent association of mannose-binding lectin-2 genetic variants on HIV-1-related disease in children.
    Singh KK; Lieser A; Ruan PK; Fenton T; Spector SA
    J Allergy Clin Immunol; 2008 Jul; 122(1):173-80, 180.e1-2. PubMed ID: 18602571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HBV/HIV co-infection and APOBEC3G polymorphisms in a population from Burkina Faso.
    Compaore TR; Diarra B; Assih M; Obiri-Yeboah D; Soubeiga ST; Ouattara AK; Tchelougou D; Bisseye C; Bakouan DR; Compaore IP; Dembele A; Djigma WF; Simpore J
    BMC Infect Dis; 2016 Jul; 16():336. PubMed ID: 27449138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 Vif can directly inhibit apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3G-mediated cytidine deamination by using a single amino acid interaction and without protein degradation.
    Santa-Marta M; da Silva FA; Fonseca AM; Goncalves J
    J Biol Chem; 2005 Mar; 280(10):8765-75. PubMed ID: 15611076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure and real-time monitoring of the enzymatic reaction of APOBEC3G which is involved in anti-HIV activity.
    Furukawa A; Nagata T; Matsugami A; Habu Y; Sugiyama R; Hayashi F; Kobayashi N; Yokoyama S; Takaku H; Katahira M
    Nucleic Acids Symp Ser (Oxf); 2009; (53):87-8. PubMed ID: 19749273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restriction of HIV-1 by APOBEC3G is cytidine deaminase-dependent.
    Browne EP; Allers C; Landau NR
    Virology; 2009 May; 387(2):313-21. PubMed ID: 19304304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts.
    Mangeat B; Turelli P; Caron G; Friedli M; Perrin L; Trono D
    Nature; 2003 Jul; 424(6944):99-103. PubMed ID: 12808466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.